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The ubiquitin–proteasome pathway has a well-
defined beginning and end. Target proteins are
initially recognized by upstream components and
tagged with polyubiquitin chains. The 26S pro-
teasome then degrades these polyubiquitinated
proteins. Until recently, it was not known what, if
any, steps occurred between the initial polyubiq-
uitination of target proteins and their final degra-
dation. Several new papers investigating the
function of the Cdc48–Ufd1–Npl4 complex indi-
cate that there is indeed a middle to the ubiqui-
tin–proteasome pathway. The Cdc48–Ufd1–Npl4
complex functions in the recognition of several
polyubiquitin-tagged proteins and facilitates their
presentation to the 26S proteasome for proces-
sive degradation or even more specific process-
ing. The elucidation of Cdc48, Ufd1 and Npl4
action not only provides long-sought functions for
these specific proteins, but illuminates a poorly
understood part of the ubiquitin–proteasome
pathway.
Introduction
Geneticists hunt for mutants by casting very large
nets, and it is often not obvious which genes will ulti-
mately prove to be prize-winning catches, nor who
has been fishing in the same waters. NPL4 and CDC48
were netted in separate expeditions to understand
nuclear transport and the cell cycle. However, recent
studies have shown these two distinct trophies to be
intimately involved in a poorly understood part of the
ubiquitin–proteasome pathway of degradation. In this
pathway, multiple copies of the small protein (8 kDa)
ubiquitin are covalently attached to a target protein,
creating a polyubiquitin chain that serves as a signal
for processive degradation, or even specific cleavage,
by the 26S proteasome. Although the machinery of
ubiquitination and the 26S proteasome are under
intense scrutiny [1–3], much less is known about what
happens in vivo between the actual ubiquitination of a
protein and its processing by the 26S proteasome.
From elegant in vitro experiments, it is clear that
highly purified 26S proteasomes can alone recognize
ubiquitinated proteins and degrade them [4–6]. But is
this sufficient in vivo? In the cell, there are many possi-
ble impediments to 26S degradation of ubiquitinated
substrates. These can include removal from mem-
branes or compartments, dissociation from multiprotein
complexes, or disassembly of a targeted substrates.
This review discusses recent studies that suggest there
can be a ‘middle’ to the ubiquitin–proteasome pathway
and that the proteins coded by NPL4, UFD1 and CDC48
participate in this stage of the pathway by recognizing
a variety of ubiquitinated proteins and presenting them
to the 26S proteasome.
NPL4: Out of the Pore House, and into the ER
NPL4 is an essential gene that was first identified in a
selection for mutants defective in nuclear import [7].
At a restrictive temperature, npl4 mutants fail to import
proteins bearing a nuclear localization sequence (NLS).
They have gross defects in nuclear morphology and
membrane herniations similar to those seen when
some actual pore proteins, such as Nup116, are
missing [7,8]. Although these phenotypes are consis-
tent with a role in nuclear transport, Npl4 has never
been identified as a bona fide component of the
nuclear pore despite exhaustive and highly effective
efforts to identify all components of this complex in
yeast [9–12]. Recent data from an entirely different
genetic screen clearly implicates Npl4 in the ubiqui-
tin–proteasome degradation pathway.
In isolating hrd mutants that fail to degrade the
enzyme HMG-CoA reductase, Bays et al. [13] found an
allele of NPL4, hrd4-1, broadly deficient in ER-associ-
ated degradation, stabilizing both misfolded and
normal proteins degraded by this pathway. The origi-
nal npl4-1 and npl4-2 alleles isolated in the npl selec-
tion were also strongly deficient in ER-associated
degradation at a temperature permissive for nuclear
import and export, suggesting that a defect in ER-
associated degradation was a primary phenotype in
npl4/hrd4 mutants [13], and not a secondary result of
deficient nuclear transport. This was further supported
by the observation that ER-associated degradation
proceeds normally when nuclear import and export
are blocked in a nup116∆ mutant — a null in a gene
encoding an actual component of the pore with
nuclear phenotypes strikingly similar to those of npl4
mutants [7,8,13]. As it had been previously noted that
deficiencies in the ubiquitin–proteasome pathway can
compromise nuclear import and export [14,15], the
finding that npl4/hrd4 mutant cells suffer primarily
from a block in ubiquitin-mediated degradation was
not completely shocking.
The ER-associated degradation defect in npl4
mutants is quite general. The npl4 defect crosses
several ubiquitin ligase boundaries in stabilizing both
misfolded and regulated proteins. In order to deter-
mine where Npl4/Hrd4 acts in the ubiquitin-protea-
some pathway, ubiquitination of HMG-CoA reductase
(HMGR) was assayed in hrd4-1 mutant cells. In these
strains, HMGR is fully ubiquitinated, consistent with
the defect being downstream of ubiquitination [13].
Although this would be consistent with a defect in
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proteasome function, Npl4 has never been suggested
to be a proteasome subunit. And general proteasome
function is not deficient in npl4 mutant strains as
shown using several cytosolic test substrates [13].
The study of npl4 and hrd4 mutants makes two
important points about Npl4 function. First, Npl4 shows
an ‘ER-centric’ behavior in that it is broadly required for
ER protein degradation, but does not seem to affect
cytosolic protein degradation [13]. (Loss of Npl4 also
induces an unfolded protein response [13].) Second,
Npl4 appears to act at a post-ubiquitination but pre-
proteasome step in ER-associated degradation as the
ER membrane protein HMGR is fully ubiquitinated but
not degraded in npl4/hrd4 mutant cells. Npl4/Hrd4
therefore represents a previously uncharacterized step
in ubiquitin-mediated protein degradation at the ER.
The presence of this intermediate step is further indi-
cated by study of the Cdc48/p97 protein and its binding
partners.
Cdc48 Finally Finds a Function Free from Fusion
The AAA ATPase Cdc48 — also known as p97 or
Valosin-containing protein, VCP — has been impli-
cated in an even wider variety of cellular processes
than Npl4, but like Npl4, recent data suggest that
cdc48 phenotypes are caused by a defect in the ubiq-
uitin–proteasome pathway, and specifically at a step
after ubiquitination. It has been known for some time
that CDC48 is required for the ubiquitin-mediated
degradation of several short-lived proteins including
N-end rule substrates and IκBα [16,17]. In the study of
IκBα degradation and a large-scale study to identify
proteasome-interacting proteins, Cdc48 was found to
associate physically with the 26S proteasome in an
ATP-dependent manner [17,18]. This raised the
intriguing possibility that Cdc48 may act in the pre-
sentation of at least certain substrates to the 26S pro-
teasome. Recent data support this idea and suggest
that a Cdc48 complex acts broadly in the recognition
and presentation of ubiquitinated proteins to the 26S
proteasome.
Strikingly, Cdc48 can selectively recognize ubiquiti-
nated proteins. In one study Dai and Li [19] find that
several polyubiquitinated proteins copurify with VCP,
the mammalian homologue of Cdc48, when tagged
versions of VCP are affinity-purified from whole cell
lysates. This copurification of polyubiquitinated pro-
teins is inhibited by the addition of increasing amounts
of tetra-ubiquitin chains. VCP preferentially binds
tetra-ubiquitin chains in an ATP-dependent manner,
with little affinity for mono-, di-, and tri-ubiquitin mol-
ecules in vitro [19]. This preference is especially inter-
esting as tetra-ubiquitin is apparently a preferential
unit in the recognition of polyubiquitin chains, and
thus would be consistent with Cdc48 as a polyubiqui-
tin chain binding protein [20,21].
The relevance of Cdc48’s ability to recognize poly-
ubiquitinated proteins is revealed by studies of virally-
induced ER protein degradation. In an attempt to
escape detection by the immune system, the
cytomegalovirus (CMV) gene product US11 orches-
trates retrograde translocation of MHC class I heavy
chain proteins from the ER to the cytosol for rapid
degradation by the 26S proteasome [22,23]. In a
recent paper, Ye et al. [24] show that MHC retro-
translocation requires the mammalian Cdc48 homo-
logue, p97. In semi-permeabilized cells expressing
US11, addition of a dominant-negative version of p97
mutated in its conserved ATPase domain interferes
with MHC retrotranslocation while an equal amount of
wild-type p97 added to this in vitro system has no
effect. This lack of wild-type effect may be due to the
need for adding p97 complexes that include mam-
malian Npl4 and Ufd1 as well (see below).
If proteasome activity is inhibited in US11-express-
ing or CMV-infected cells, ubiquitinated heavy chain
proteins can be found in the cytosol as degradation
fails to follow retrotranslocation [23]. Importantly, Ye
et al. [24] showed this was not the case when a dom-
inant-negative p97 protein was present in the perme-
abilized assay. The p97 dominant-negative resulted in
accumulation of ubiquitinated heavy chain proteins in
a microsomal cell fraction rather than a soluble,
cytosolic fraction as occurred when an equal amount
of wild-type p97 was added under the same assay
conditions [24]. Thus, blocking Cdc48/p97 activity had
no apparent effect on the actual ubiquitination of
heavy chain proteins, just as blocking Npl4 function in
yeast also left ER-localized proteins fully ubiquiti-
nated. In the case of US11-induced heavy chain
degradation, this block occurs at the actual step of
retrotranslocation of heavy chain proteins to the cytosol.
Unfortunately, no dominant-negative mutants of Npl4
are currently available to test whether blocking Npl4
activity in the Ye et al. experiments would also block
retrotranslocation of heavy chain proteins, but there is
very good reason to suspect that Npl4 acts with Cdc48
in US11-mediated retrotranslocation — with the first
hints of guilt occurring by association. Cdc48 physically
associates with an impressive array of proteins in the
Figure 1. The Cdc48–Ufd1–Npl4 complex acts in ER-
associated protein degradation.
Here, the ER membrane protein HMG-CoA reductase is tagged
for proteasomal degradation by the addition of polyubiquitin
chain(s). A Cdc48p–Ufd1p–Npl4p complex is then required for
degradation by the 26S proteasome. A deficiency in any
complex member results in HMG-CoA reductase or other ER
degradation substrate remaining fully ubiquitinated but unable
to be degraded by a fully functional 26S proteasome. 
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cell, and one Cdc48 complex is composed of Cdc48,
Npl4 and Ufd1. Both Bays et al. [13] and Ye et al. [24]
report that each member of this complex is required for
ER-associated degradation and loss of each one
results in a broad defect in this process — even at each
mutant’s permissive temperature (all three genes are
essential). A requirement for Cdc48 in ER-associated
degradation has also been described by Rabinovich et
al. [25].
Experiments in the Ye et al. paper [24] suggest that
the entire Cdc48–Ufd1–Npl4 complex does indeed act
at the same step in ER-associated degradation (illus-
trated in Figure 1). These experiments exploit the
observation that the protein p47 competes with
Ufd1–Npl4 for binding of Cdc48. When Ye et al. [24]
added excess p47 to permeabilized cells to displace
Ufd1–Npl4, retrotranslocation of heavy chains was
blocked, consistent with a requirement for Npl4–Ufd1
binding to Cdc48 in this action. Unfortunately, p47 is
not a benign Cdc48 binding partner, and p47 even
decreases Cdc48 ATPase activity — an activity
required for Cdc48 to function in heavy chain retro-
translocation.
An even more recent paper by Jarosch et al. [26]
studying the mutant, misfolded form of carboxypepti-
dase Y, CPY*, shows that loss of Ufd1 also blocks ER-
associated degradation at a post-ubiquitination but
pre-proteasome step. In order to be degraded by the
cytosolic 26S proteasome, CPY* must be retro-
translocated from the ER lumen to the cytosol.
Jarosch et al. [26] show that polyubiquitination by the
ubiquitin-protein ligase Hrd1 and its associated ubiq-
uitin-conjugating enzymes Ubc7 and Ubc1 is required
for this retrotranslocation. While polyubiquitination of
CPY* is blocked by hrd1∆ or ubc1∆/ ubc7∆ mutations,
CPY* is fully ubiquitinated in wild-type and ufd1-1
mutant cells.
Intriguingly, CPY* is also fully ubiquitinated in pro-
teasome mutant strains, but in these strains ubiquiti-
nated CPY* can be found in both cytosolic and ER
membrane fractions showing that a fraction of CPY* is
being retrotranslocated but not degraded when pro-
teasome activity is compromised. This differs from
wild-type and ufd1-1 strains where polyubiquitinated
CPY* is found exclusively in ER membrane fractions.
Therefore, ufd1-1 and proteasome mutant strains are
blocked in CPY* degradation at a step following ubiq-
uitination but only ufd1-1 strains are blocked in CPY*
retrotranslocation, consistent with a role for the
Cdc48–Ufd1–Npl4 complex in the retrotranslocation of
substrates for ER-associated degradation.
Cdc48–Ufd1–Npl4 Picks at the Remains of a
Transcription Factor
The model that the entire Cdc48–Ufd1–Npl4 complex
acts in the ubiquitin–proteasome pathway is further
supported by studies of a novel role for the ubiquitin–
proteasome pathway in the processing of an ER-
bound transcription factor. The activities of transcrip-
tion factors are regulated in diverse ways. One of the
more recently discovered modes involves the regu-
lated cleavage of transcription factors from trans-
membrane anchors, allowing the active transcription
factor domain to enter the nucleus and regulate gene
expression. The first such transcription factor to be
characterized was SREBP (sterol regulatory element
binding protein), required for transcription of sterol
synthetic genes. SREBP is cleaved by the action of
specific proteases to release a soluble, active tran-
scription factor [27,28].
Recent work in the Jentsch and Silver labs has
shown that the 26S proteasome can also participate
in the regulated cleavage of transcription factors from
their transmembrane anchors. Hoppe et al. [29] and
Hitchcock et al. [30] show that the Cdc48–Ufd1–Npl4
complex plays a central role in this proteasome-
dependent processing. Both of these studies [29,30]
investigated the mechanism of Spt23 and Mga2 regu-
lation. These two transcription factors are synthesized
as integral ER membrane proteins and are required for
the transcription of OLE1 mRNAs coding for Ole1, an
essential ∆9-fatty acid desaturase in Saccharomyces
cerevisiae [30,31]. In order to activate transcription of
OLE1, the transcriptionally active portions of Spt23
and Mga2 must be cleaved from their transmembrane
domains. This cleavage requires ubiquitination and
the 26S proteasome [29].
Hitchcock et al. [30] reported that CDC48, UFD1
and NPL4 are each required for the efficient process-
ing of Spt23 and Mga2. When cdc48, ufd1 and npl4
mutant cells are shifted to a restrictive temperature,
Spt23 and Mga2 are less efficiently cleaved from their
transmembrane domains and the majority of Spt23
and Mga2 remains as full-length protein at the ER [30].
Consistent with a deficiency in processing, these
same mutants show reduced expression of OLE1
mRNA [30].
In a related paper, Rape et al. [33] study the role 
of Cdc48–Ufd1–Npl4 in Spt23 and Mga2 processing,
but focus on events that occur after the proteaso-
mal cleavage of Spt23 and Mga2. They show that
when Spt23 is cleaved by the 26S proteasome, the
active transcription factor domain (p90) can remain
physically associated with the larger, unprocessed
p120. Their studies implicate the Cdc48–Ufd1–Npl4
complex in the dissociation of processed p90 from
the membrane anchored p120. When membrane 
fractions were isolated from yeast cells, both p120
and p90 were detected, as p90 remains associated
with p120. Addition of Cdc48-expressing insect cell
extracts caused the release of p90 from p120 and 
its appearance in the soluble fraction. Insect cell
extract lacking Cdc48 did not cause this same mobi-
lization of p90. Furthermore, addition of apyrase (to
remove ATP) and NEM (to inhibit Cdc48 activity)
blocked the ability of Cdc48-containing extract to
mobilize p90 [33,34].
When p120 and p90 membrane fractions were iso-
lated from npl4-1 cells, Cdc48 was not able to cause
the dissociation of p90 from p120 despite the lower
levels of p90 produced due to the less efficient cleav-
age of p120 in npl4-1 strains. From these in vitro
studies, it appears that Cdc48 is indeed acting as a
chaperone in dismantling the protein–protein interac-
tion between p90 and p120. What is striking about this
Cdc48 chaperone action is that Cdc48 selectively
binds the ubiquitinated protein in this complex. The
term ‘segregase’ has been suggested for this action of
Cdc48 [35].
To characterize processing more fully, Rape et al.
[33] compared p90 generated naturally or from a
coding region lacking the transmembrane region and
only expressing the processed p90 fragment, referred
to as Spt23p∆TM. They found that p90 derived from
full-length Spt23 is ubiquitinated whereas the inde-
pendently produced p90 is not. Thus, the ubiquitina-
tion of p90 comes about by its release from full-length
Spt23. Importantly, only the ubiquitinated p90 physi-
cally associates with Cdc48 while nonubiquitinated
Spt23p∆TM does not. Rape et al. [33] also showed
that Cdc48 associates with the unstable and ubiquiti-
nated N-end rule/ubiquitin fusion degradation (UFD)
pathway substrate Ub–Pro-β galactosidase while
Cdc48 does not associate with the stable and non-
ubiquitinated Ub–Met-β galactosidase. When added
to other data in the paper, these results strongly
suggest that Cdc48 can act as a chaperone with
specificity for ubiquitinated proteins.
A comparison of the Hitchcock et al. [30] and Rape
et al. [33] papers illustrates important features of the
Cdc48–Ufd1–Npl4 complex. These two papers join
Bays et al. [13] and Ye et al. [24] in showing instances
where loss of function in the Cdc48–Ufd1–Npl4
complex results in ER proteins being fully ubiquiti-
nated yet unprocessed by the 26S proteasome. Hitch-
cock [30] and Rape [33] both show the accumulation
of ubiquitinated but unprocessed p120 in cdc48, npl4,
and ufd1 mutants. Likewise, Bays et al., [13] Ye et al.
[24] and Jarosch et al. [26] show ubiquitinated HMG-
CoA reductase, ubiquitinated MHC heavy chains, and
ubiquitinated CPY* are all stuck at the ER membrane,
escaping the processive degradation and even retro-
translocation seen in wild-type cells.
The Hitchcock [30] and Rape [33] papers also
emphasize two different functions for the
Cdc48–Ufd1–Npl4 complex in the same OLE pathway
(Figure 2). Hitchcock et al. [30] show that the effi-
ciency of Spt23 and Mga2 processing is reduced
when components of the Cdc48–Ufd1–Npl4 complex
are compromised. Because cells must produce OLE1
transcript in order to live, processing is not completely
absent in the cdc48, npl4 and ufd1 mutants tested,
but it is clearly less efficient. Rape et al. [33] show that
the Cdc48–Ufd1–Npl4 complex is not just required for
processing of Spt23, but that the complex is also
required to separate the processed p90 protein from
the p120 protein — a process that does not require
the 26S proteasome. Here, in the same pathway, there
are different uses for the ability of Cdc48–Ufd1–Npl4
to recognize selectively ubiquitinated proteins, and at
least in one case to act as a molecular chaperone.
The study of the OLE pathway also provides yet
another example of Cdc48–Ufd1–Npl4 action in ER-
associated degradation. In an additional Jentsch lab
paper, Braun et al. [35] show that the membrane bound
Ole1 protein itself is unstable and undergoes ER-asso-
ciated degradation. Degradation of Ole1 requires each
member of the Cdc48–Ufd1–Npl4 complex: cdc48,
ufd1 and npl4 mutants were each deficient in the degra-
dation of Ole1.
Cdc48–Ufd1–Npl4 : Resolving Con-Fusion About
Mutants
These recent data regarding the function of the
Cdc48–Ufd1–Npl4 complex serve to make sense of
diverse and seemingly disparate phenotypes, espe-
cially those originating from cdc48 and npl4 mutants.
They also present compelling avenues of investiga-
tion. It is now a reasonable hypothesis that all npl4
and cdc48 phenotypes involve, somehow, loss of
function in ubiquitin- or proteasome-mediated path-
ways. Therefore, processes involving the Cdc48–
Ufd1–Npl4 complex, but with no known ubiquitin/pro-
teasome connection, now elicit an investigation into
whether ubiquitin/proteasome is involved. One example
of such a process is membrane fusion. Cdc48 has
been implicated for some time in homotypic ER mem-
brane fusion [36] and Golgi vesicle fusion [37,38], but
its role has not been extensively characterized. A
recent report by Hetzer et al. [39] shows that Cdc48–
Ufd1–Npl4 is required for membrane fusion, specifi-
cally to form a closed nuclear envelope at the end of
mitosis in larger eukaryotes. Given this requirement
for Cdc48–Ufd1–Npl4, it may be informative to seek
directly roles for ubiquitin/proteasome in nuclear
envelope formation specifically and in membrane
fusion generally.
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Figure 2. The Cdc48–Ufd1–Npl4p
complex acts at several stages of tran-
scription factor Spt23 processing.
(A) The complex is first required for the
proteasome-dependent cleavage of the
Spt23 transcription factor domain (p90)
from its transmembrane anchor. (B) After
cleavage, p90 remains associated with
full-length Spt23p (p120). (C) Cdc48p-
Ufd1p-Npl4p is also required for the sep-
aration of this dimer, allowing p90 to enter
the nucleus and promote the transcription
of OLE1 mRNA.
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Investigation of other processes requiring a func-
tional Cdc48–Ufd1–Npl4 complex may well begin with
models involving ubiquitin/proteasome. For instance,
the mammalian homologue of Cdc48/VCP is currently
being studied in the case of neural degeneration caused
by polyglutamine-containing proteins. In work by the
Kakizuka lab [40,41], VCP has been implicated as a
factor that modifies the progress of this important and
general pathway of neural death. Several models impli-
cate the ubiquitin–proteasome pathway in the dying
efforts of a neural cell to clear damaged proteins, and
Cdc48/VCP may further strengthen this connection.
New structural observations suggest an alternative
to the ‘ubiquitin only’ interpretation for some functions
of the Cdc48 complex. As mentioned earlier, p47 is a
binding partner of Cdc48 and appears to act with
Cdc48p in mediating certain membrane dynamics.
The carboxy-terminal portion of p47 has a ubiquitin-
like UBX domain. NMR studies now indicate that,
despite the limited homology to ubiquitin (~14% iden-
tity), the tertiary structure of the p47 UBX domain is
essentially superimposable with authentic ubiquitin
[42]. This raises the intriguing possibility that p47 sub-
stitutes partially or completely for ubiquitin in some
actions of the Cdc48 complex, allowing the same
nanomechanical actions to be performed on molecules
that are not ubiquitinated, but can interact with this
clever ‘p47-in-ubiquitin's clothing’.
Further Study of the Cdc48–Ufd1–Npl4 Complex
Far more mechanistic information has been charac-
terized for Cdc48 than for Npl4 or Ufd1. Data from the
papers discussed here and elsewhere indicate that
Cdc48 can act as an ATP-dependent chaperone, and
Cdc48 can bind many different proteins — several of
which are known to modulate directly its function
[16,43–46]. Not much more is known about Ufd1 and
Npl4 other than they are part of the long list of Cdc48-
binding proteins and that they are both required for
several ubiquitin- or proteasome-mediated processes. 
To complicate the study of Cdc48–Ufd1–Npl4 further,
the substrate range for Cdc48, Ufd1 and Npl4p implies
that the three proteins do not always act together in
ubiquitin-mediated protein degradation. While Cdc48
is required for the degradation of both N-end rule and
UFD pathway substrates [16], Ufd1 is only required for
the degradation of UFD substrates and not N-end rule
substrates [47]. Npl4 is required for neither group of
substrates [13]. (One experiment in Rape et al. [33]
does show stabilization of Ub–Pro-β galactosidase in
a npl4-1 strain but the chase was performed after incu-
bation at the restrictive temperature. The experiments
in Bays et al. [13] testing cytosolic N-end rule, UFD
and Deg1 substrates were all performed at the per-
missive temperature where npl4/hrd4 mutants show a
strong block in ER-associated degradation.) Discov-
ering exactly how Ufd1 and Npl4 affect Cdc48 func-
tion will undoubtedly become a major focus in future
studies of Cdc48–Ufd1–Npl4 function.
Cdc48–Ufd1–Npl4 has broader implications for the
nature of the ubiquitin–proteasome system. The phe-
notypes resulting from loss of this complex strongly
suggest that there can be intermediate steps following
ubiquitination that must take place in order for a ubiq-
uitinated protein to be recognized and processed by
the 26S proteasome. Now studies will focus on how
general the requirement for an intermediate step is,
what events are actually occurring in such intermedi-
ate steps, and how many different proteins can act as
an intermediary between ubiquitinated proteins and
the 26S proteasome. All of these studies will produce
exciting and illuminating insights into the ubiquitin–pro-
teasome pathway.
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